NEW ALBANY, OH, May 16, 2018 -- Myonexus Therapeutics, a clinical-stage gene therapy company developing first ever corrective gene therapies for limb girdle muscular dystrophies, and Nationwide ...
NEW ALBANY, Ohio--(BUSINESS WIRE)--Myonexus Therapeutics, a clinical-stage gene therapy company developing first-ever corrective gene therapies for Limb-girdle muscular dystrophies (LGMD), announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback